Colamonici O R, Domanski P, Platanias L C, Diaz M O
Section of Hematology/Oncology, University of Chicago, IL 60637-1470.
Blood. 1992 Aug 1;80(3):744-9.
Homozygous and hemizygous deletions of the interferon A (IFNA) and IFNB genes have been frequently observed in acute leukemia cell lines, primary acute leukemia cases, and gliomas. Because IFNs have an antiproliferative effect, selection against the IFN alpha/beta system could play a role or accompany the development of the malignant phenotype. Although the deletion of the IFNA/B genes could interrupt an autocrine loop that controls cell proliferation, cells would still respond to exogenous IFN alpha/beta and, thus, lesions at the receptor or signal transduction level should also be present to render cells resistant to exogenous IFN alpha/beta. To test if selection against the IFN system was operating in acute leukemias, the sensitivity to the antiproliferative effect of IFN alpha 2 was studied in acute leukemia cell lines with and without alterations of the IFNA/B genes. We found that 10 of 11 acute leukemia cell lines with alterations of the IFNA/B genes were resistant to the antiproliferative effect of IFN alpha 2, whereas only two of eight cell lines with normal IFNA/B genes were IFN-resistant. We then examined the possibility that an alteration of the receptor expression could account for the lack of response to IFN alpha 2. No significant alteration in the expression or structure of the IFN alpha receptor was observed. We also studied the downmodulation of the alpha subunit of the IFN alpha receptor upon IFN alpha 2 binding. One cell line with deletion of the IFNA/B genes showed impaired downmodulation of the IFN alpha receptor. The data presented here suggest that selection against the IFN alpha/beta system could play a role or accompany the development of the malignant phenotype.
在急性白血病细胞系、原发性急性白血病病例和神经胶质瘤中,经常观察到干扰素A(IFNA)和干扰素B(IFNB)基因的纯合和半合子缺失。由于干扰素具有抗增殖作用,针对干扰素α/β系统的选择可能在恶性表型的发展中起作用或与之相伴。尽管IFNA/B基因的缺失可能会中断控制细胞增殖的自分泌环,但细胞仍会对外源性干扰素α/β产生反应,因此,受体或信号转导水平的损伤也应存在,以使细胞对外源性干扰素α/β产生抗性。为了测试针对干扰素系统的选择是否在急性白血病中起作用,我们研究了具有或不具有IFNA/B基因改变的急性白血病细胞系对干扰素α2抗增殖作用的敏感性。我们发现,11个具有IFNA/B基因改变的急性白血病细胞系中有10个对干扰素α2的抗增殖作用具有抗性,而8个IFNA/B基因正常的细胞系中只有2个对干扰素具有抗性。然后,我们研究了受体表达改变是否可以解释对干扰素α2缺乏反应的可能性。未观察到干扰素α受体的表达或结构有明显改变。我们还研究了干扰素α2结合后干扰素α受体α亚基的下调情况。一个具有IFNA/B基因缺失的细胞系显示干扰素α受体的下调受损。本文提供的数据表明,针对干扰素α/β系统的选择可能在恶性表型的发展中起作用或与之相伴。